Cilostazol/Borneol

西洛他唑/冰片

Report date: 2025/06/05 20:00:13
NME

Base Information

Drug NameCilostazol/Borneol
Drug Alias NameY-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3
Therapy Area/IndicationsIschemic StrokeArterial Occlusive DiseasesStroke +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes CilostazolBorneol
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNeuroDawn Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuroDawn Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeArterial Occlusive DiseasesStroke +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A